Article Details
Retrieved on: 2025-04-02 22:57:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses various biotech topics, including the positive impact of GLP-1 receptor agonists like liraglutide and semaglutide in neurodegeneration, and the challenges faced by the biopharma investment sector, linking these to biopharmaceutical themes such as peptide therapeutics and cardiac health.
Article found on: www.bioworld.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here